A detailed history of Atalan Capital Partners, LP transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Atalan Capital Partners, LP holds 189,000 shares of TMO stock, worth $117 Million. This represents 9.74% of its overall portfolio holdings.

Number of Shares
189,000
Previous 203,000 6.9%
Holding current value
$117 Million
Previous $118 Million 11.42%
% of portfolio
9.74%
Previous 9.79%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$541.52 - $599.02 $7.58 Million - $8.39 Million
-14,000 Reduced 6.9%
189,000 $105 Million
Q4 2023

Feb 14, 2024

BUY
$431.41 - $532.94 $14.2 Million - $17.6 Million
33,000 Added 19.41%
203,000 $108 Million
Q3 2023

Nov 14, 2023

BUY
$498.29 - $574.41 $47.3 Million - $54.6 Million
95,000 Added 126.67%
170,000 $86 Million
Q2 2023

Aug 14, 2023

BUY
$508.46 - $591.13 $38.1 Million - $44.3 Million
75,000 New
75,000 $39.1 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $242B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Atalan Capital Partners, LP Portfolio

Follow Atalan Capital Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atalan Capital Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Atalan Capital Partners, LP with notifications on news.